ChAd63 ME-TRAP and MVA ME-TRAP

BIOLOGICAL3 trials

Sponsors

University of Oxford

Conditions

Malaria

Phase 1

A Phase 1/2b Study of an Investigational Malaria Vaccination Strategy in 5-17 Month Old Infants and Children in Burkina Faso

CompletedNCT01635647

University of OxfordMalaria

Start: 2012-11-30End: 2014-09-30Updated: 2016-02-15

Phase 2

Efficacy of Candidate Malaria Vaccines in Senegalese Adults

CompletedNCT01658696

University of OxfordMalaria

Start: 2012-08-31End: 2013-02-28Updated: 2013-12-12

Unknown Phase

A study to find out if a new malaria vaccine regimen can protect against malaria in African adults.

Active, not recruitingPACTR201202000356208

University of OxfordMalaria

Start: 2012-02-01Target: 120Updated: 2026-09-14

Related Papers

Impact of exposure to malaria and nutritional status on responses to the experimental malaria vaccine ChAd63 MVA ME-TRAP in 5-17 month-old children in Burkina Faso

Frontiers in Immunology2022-12-029 citations

First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children

PLoS ONE2018-12-1292 citations